Diphenylhydantoin as an anticonvulsant: evaluation of treatment in forty mentally subnormal epileptics.
D000293:Adolescent; D000328:Adult; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy*; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D008297:Male; D010672:Phenytoin / Q000008:administration & dosage* / Q000097:blood / Q000134:cerebrospinal fluid; D013223:Statistics as Topic
D010672:Phenytoin; D002746:Chlorpromazine